Skip to content

SALES4BIO

Active Private limited companyfounded 2019active for 6 yearsVerbrandhofstraat 8, 8800 RoeselareKBO/BCE: BE 0740.507.502

Lifetime

6 annual accounts with figures on one time axis
peak of €100,694 in 2022
€8,300▼ 63.7%
lowest -€80,813 in 2023
-€5,787▲ €10,644
peak of €22,465 in 2021
-€115,313▼ €5,787
€154,913▼ 10.5%
peak of 2.8 FTE in 2022
0 FTE 
Board1 name since 2019
1 director
Documentsfilings and deeds
23-07-20268 days before the deadline
2025abbreviated format
Gross margin from €22,863 to €8,300Loss of €5,787Cash from €8,702 to €921

Key points

from the 2025 annual accounts

Equity

-€115,313
202020212022202320242025

Debts exceed assets in financial year 2025.

Losses

-€137,777 in four years
-34,7452022-80,8132023-16,4312024-5,7872025

Every financial year from 2022 to 2025 closed with a loss. 2023 was the heaviest.

Turnover

≈ €47,000 estimated

The abbreviated format states no turnover.

Debts

€154,913 391% of the balance sheet
Financial debts 81%Suppliers 11%Taxes and wages 1%Other 7%

Filings

6 annual accounts 2 late
AprilJune31 JulyOctober202020222024

The 2024 accounts came in latest, 232 days after the end of the period.

Position in the sector

-291.2%

Lower solvency than 95% of companies in advertising and market research. The sector median is 42.9%, over 1,975 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,008 companies had the same profile as SALES4BIO has now. Each dot stands for 16 companies, two years later.

83.0%
were still trading
8.5%
stopped another way
8.1%
went bankrupt
  • Micro
  • 5 to 10 years old
  • negative equity
  • a loss of 10% of the balance sheet or more

Another 0.4% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,008 companies, not a prediction for SALES4BIO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 23-12-2019
  • 45 sharesdeed of 31-12-2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0740507502
Incorporation Founding capital of €4,500, 45 shares · Founded by · appointed as director · published on 31-12-2019 · Gazette deed
First establishment Verbrandhofstraat 8, Roeselare
All 10 events

Comparable companies

same main activity, similar in size and age
Company
SALES4BIO Roeselare €39,601 €8,300 -291.2% 0
Vinck Management Consult Hulshout €99,229 €8,826 89.5% 0
MUGNOMA Knokke-Heist €53,918 €6,446 89.7% -
baltus architectural engineering Antwerp €30,168 €14,605 33.2% -
SmartData Agency Brussels €38,101 €9,871 -11.2% -
N2 Middelkerke €31,720 €20,697 44.7% -
Rudimentary Oostkamp €92,565 €11,605 3.8% -

These companies have the same main activity as SALES4BIO: market research and public opinion polling (NACE 73200). They are comparable in size and age: total assets between €30,200 and €99,200, founded between 2018 and 2021.

Official details

Source: KBO
Status
Active since 27-12-2019Normal situation
Activity
Market research and public opinion pollingNACE 73200and 4 others
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 2024
Establishment unit
2.297.644.1468800 Roeselare, since 27-12-2019
Financial year end
31 December
Peppol
Reachable since 22-11-2024
Company details

Annual accounts 2025

€39,601▼ 37.6%
Filing
Filed on 23-07-2026, 8 days before the end of the filing period
Financials

Insights on SALES4BIO

SALES4BIO files the abbreviated format. That format states no turnover. The gross margin fell from €23,385 in 2020 to €8,300 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about SALES4BIO

What is the company number of SALES4BIO?
The company number of SALES4BIO is 0740.507.502. The VAT number is the same number with BE in front: BE 0740.507.502.
Where is SALES4BIO based?
The registered office is at Verbrandhofstraat 8, 8800 Roeselare.Company details
What does SALES4BIO do?
According to the KBO register, the main activity is market research and public opinion polling (NACE 73200).
What is the legal form of SALES4BIO?
SALES4BIO is a private limited company (BV).
When was SALES4BIO founded?
SALES4BIO was founded on 27-12-2019.
Is SALES4BIO still active?
Yes, SALES4BIO is an active enterprise in the KBO register.
How many employees does SALES4BIO have?
SALES4BIO had an average of 2.2 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
Which joint committee does SALES4BIO fall under?
In its 2024 annual accounts, SALES4BIO states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of SALES4BIO?
The turnover in financial year 2025 is about €47,000. This figure is estimated from the gross margin of €8,300 and 108 comparable companies (NACE 73). It probably lies between €24,000 and €85,000. It is a rough estimate.
Is SALES4BIO profitable?
In financial year 2025, SALES4BIO made a loss of €5,787.
Where can I find the annual accounts of SALES4BIO?
SALES4BIO filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SALES4BIO due?
SALES4BIO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.